Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study-Reference-Cited by-同舟云学术

Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study

Published:2015-12-29 Issue:12 Volume:12 Page:e1001932
ISSN:1549-1676
Container-title:PLOS Medicine
language:en
Short-container-title:PLoS Med

Author:

Yuen Courtney M.,Kurbatova Ekaterina V.,Tupasi Thelma,Caoili Janice Campos,Van Der Walt Martie,Kvasnovsky Charlotte,Yagui Martin,Bayona Jaime,Contreras Carmen,Leimane Vaira,Ershova Julia,Via Laura E.,Kim HeeJin,Akksilp Somsak,Kazennyy Boris Y.,Volchenkov Grigory V.,Jou Ruwen,Kliiman Kai,Demikhova Olga V.,Vasilyeva Irina A.,Dalton Tracy,Cegielski J. Peter

Publisher

Public Library of Science (PLoS)

Subject

General Medicine

Reference21 articles.

1. Guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update,2011

2. Treatment outcomes of patients with multidrug-resistant and extensively drug-resistant tuberculosis according to drug susceptibility testing to first- and second-line drugs: an individual patient data meta-analysis;ML Bastos;Clin Infect Dis,2014

3. Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality;CD Mitnick;PLoS ONE,2013

4. Aggressive regimens for multidrug-resistant tuberculosis reduce recurrence;MF Franke;Clin Infect Dis,2013

5. Improving outcomes for multidrug-resistant tuberculosis: aggressive regimens prevent treatment failure and death;GE Velasquez;Clin Infect Dis,2014

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis;PLOS Medicine;2024-05-03

2. Radiographic characteristics of rifampicin-resistant tuberculosis in the STREAM stage 1 trial and their influence on time to culture conversion in the short regimen;BMC Infectious Diseases;2024-01-30

3. Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis: a mathematical modeling analysis;2023-07-31

4. All-oral longer regimens are effective for the management of multidrug-resistant tuberculosis in high-burden settings;European Respiratory Journal;2021-06-17

5. Management of rifampicin‐resistant TB: programme indicators and care cascade analysis in South Africa;The International Journal of Tuberculosis and Lung Disease;2021-02-01